Related references
Note: Only part of the references are listed.Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: Results from A-HeFT
Jay N. Cohn et al.
JOURNAL OF CARDIAC FAILURE (2007)
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure -: The STARS-BNP multicenter study
Patrick Jourdain et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Disease monitoring of patient with chronic heart failure
M. Gary Nicholls et al.
HEART (2007)
The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT
R Latini et al.
EUROPEAN HEART JOURNAL (2004)
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
JJV McMurray et al.
CIRCULATION (2004)
Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure - Results from the Valsartan Heart Failure Trial
JN Cohn et al.
CIRCULATION (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Structure-based design of aliskiren, a novel orally effective renin inhibitor
JM Wood et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Tonin in rat heart with experimental hypertrophy
JC Borges et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Beneficial neurohormonal profile of spironolactone in severe congestive heart failure -: Results from the RALES neurohormonal sub-study
MF Rousseau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure - The Valsartan Heart Failure Trial (Val-HeFT)
R Latini et al.
CIRCULATION (2002)
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100) - Comparison with enalapril
J Nussberger et al.
HYPERTENSION (2002)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II
B Pitt et al.
LANCET (2000)
Share Paper
